Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v11-FR | Version v10-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2022-06-23 | 2022-06-23 |
| Drug Identification Number | 02215756 | 02215756 |
| Brand name | CAVERJECT STERILE POWDER | CAVERJECT STERILE POWDER |
| Common or Proper name | CAVERJECT | CAVERJECT |
| Company Name | PFIZER CANADA ULC | PFIZER CANADA ULC |
| Ingredients | ALPROSTADIL | ALPROSTADIL |
| Strength(s) | 20MCG | 20MCG |
| Dosage form(s) | POWDER FOR SOLUTION LIQUID KIT | POWDER FOR SOLUTION LIQUID KIT |
| Route of administration | INTRACAVERNOSAL INTRACAVERNOSAL | INTRACAVERNOSAL INTRACAVERNOSAL |
| Packaging size | 5 X 20MCG | 5 X 20MCG |
| ATC code | G04BE | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-03-25 | 2022-03-25 |
| Actual start date | 2022-03-02 | 2022-03-02 |
| Estimated end date | 2022-10-31 | 2022-10-31 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Currently under preventive allocation | Currently under preventive allocation |
| Health Canada comments |